VALINK
LIVE

Serial Number

79397717

Owner

Valink Therapeutics Inc.

Attorney

Matthew A. Homyk

Filing Date

Mar 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VALINK Trademark

Serial Number: 79397717 • Registration: 7757034

VALINK is a trademark filed by Valink Therapeutics Inc. on March 5, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Valink Therapeutics Inc. (5 trademarks)

2261 Market Street #4161

Entity Type: 03

Trademark Details

Filing Date

March 5, 2024

Registration Date

April 15, 2025

Published for Opposition

February 25, 2025

Goods & Services

Chemicals for use in industry and science; biological preparations for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodies, other than for medical use; proteins for binding antibodies, other than for medical use; immunological antibodies, other than for medical use; chemical substances for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical substances for use in the production of drugs; chemicals for use in scientific research, other than medical or veterinary; chemicals for use in biotechnological product development

Scientific and technological services and research and design relating thereto in the fields of pharmaceutical, biomedical, and chemical sciences; biotechnology research; biological research; clinical research in the field of radiology and chemotherapy; medical research; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; scientific research relating to biotechnology; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemical research services of biochemistry drugs; biochemistry consultancy; biochemistry research services; biochemical research and development; research and development in the field of biotechnology; biochemical engineering services; scientific laboratory services; biochemical research laboratory services; medical research laboratory services; medical research laboratories; providing information relating to scientific research in the fields of biochemistry and biotechnology; consultancy in the field of pharmaceutical research; scientific consultancy in the field of biotechnology; consultancy relating to research and development in the field of therapeutics

Pharmaceuticals, medical and veterinary preparations for the prevention and treatment of cancer in humans and animals; pharmaceutical drugs for the prevention and treatment of cancer in humans and animals; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use for the treatment of cancer; antibodies for medical purposes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 5, 2025 OPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 22, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 19, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 19, 2025 OPNR
FINAL DISPOSITION NOTICE SENT TO IB
Nov 5, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 4, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 16, 2025 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 4, 2025 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
May 16, 2025 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 15, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 4, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 13, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 13, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 13, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 13, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 13, 2024 COAR
REFUSAL PROCESSED BY IB
Nov 17, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 29, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 15, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 9, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 21, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 21, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 20, 2024 REPR